For organ transplant recipients, cancer threatens long-term survival.
Ross
Karen
K
D020533:Angiogenesis Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000401:mortality / Q000517:prevention & control*; D016377:Organ Transplantation / Q000009:adverse effects*; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology; D020123:Sirolimus / Q000494:pharmacology* / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects; D014481:United States / Q000453:epidemiology
D020533:Angiogenesis Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D020123:Sirolimus; D016559:Tacrolimus